By proceeding, you agree to our Terms of Use and Privacy Policy.
Professor Denise Kelly former Director GT Biologics Ltd; the company is a spin-out of the Rowett Institute, University of Aberdeen and was established around the IP arising from DK's academic research spanning 17 years.
Talks About #immunology #biotechnology
Preferred Locations #Europe
From hypothetical to reality, the first ever approval of a microbiome-based therapy is here and is set to propel the industry forward, expanding across a wide range of diseases.
